Why the study?
Does antihypertensive therapy reduce cardiovascular events and mortality in adults aged 40+?
Population
Adults aged 40+ from national survey data
Comparison
Antihypertensive therapy vs No antihypertensive therapy
Design
Other
Key result
Antihypertensive therapy prevented an estimated 86,000 premature cardiovascular deaths in 2001 and generated a benefit-to-cost ratio of at least 6:1.
Authors
Loading...
Antihypertensive strategies remain cost-effective; leaves open need for updated analyses with contemporary regimens and populations.
Observational
Does antihypertensive therapy reduce cardiovascular events and mortality in adults aged 40+?
Antihypertensive therapy has provided substantial population-level health and economic benefits, preventing tens of thousands of premature cardiovascular deaths annually.
Cutler et al. (2007) conducted an observational in Hypertension. Antihypertensive therapy vs. No antihypertensive therapy was evaluated on Impact on blood pressures, cardiovascular events, and deaths. Antihypertensive therapy prevented an estimated 86,000 premature cardiovascular deaths in 2001 and generated a benefit-to-cost ratio of at least 6:1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: